TY - STD TI - Coumadin (warfarin sodium) tablets prescribing information. Bristol-Myers Squibb, Princeton, NJ. Available at: http://packageinserts.bms.com/pi/pi_coumadin.pdf (last accessed on August 4, 2014). UR - http://packageinserts.bms.com/pi/pi_coumadin.pdf ID - ref1 ER - TY - STD TI - You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang MC, Hylek EM, Schulman S, Go AS, Hughes M, Spencer FA, Manning WJ, Halperin JL, Lip GY. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e531S–75. ID - ref2 ER - TY - JOUR AU - Kearon, C. AU - Akl, E. A. AU - Ornelas, J. AU - Blaivas, A. AU - Jimenez, D. AU - Bounameaux, H. AU - Huisman, M. AU - King, C. S. AU - Morris, T. A. AU - Sood, N. AU - Stevens, S. M. AU - Vintch, J. R. AU - Wells, P. AU - Woller, S. C. AU - Moores, L. PY - 2016 DA - 2016// TI - Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report JO - Chest VL - 149 UR - https://doi.org/10.1016/j.chest.2015.11.026 DO - 10.1016/j.chest.2015.11.026 ID - Kearon2016 ER - TY - JOUR AU - Hart, R. G. AU - Pearce, L. A. AU - Aguilar, M. I. PY - 2007 DA - 2007// TI - Meta-Analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation JO - Ann Intern Med VL - 146 UR - https://doi.org/10.7326/0003-4819-146-12-200706190-00007 DO - 10.7326/0003-4819-146-12-200706190-00007 ID - Hart2007 ER - TY - JOUR AU - Brandjes, D. P. AU - Heijboer, H. AU - Büller, H. R. AU - Rijk, M. AU - Jagt, H. AU - Cate, J. W. PY - 1992 DA - 1992// TI - Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis JO - N Engl J Med VL - 327 UR - https://doi.org/10.1056/NEJM199211193272103 DO - 10.1056/NEJM199211193272103 ID - Brandjes1992 ER - TY - JOUR AU - Gallus, A. AU - Jackaman, J. AU - Tillett, J. AU - Mills, W. AU - Wycherley, A. PY - 1986 DA - 1986// TI - Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism JO - Lancet VL - 2 UR - https://doi.org/10.1016/S0140-6736(86)91431-5 DO - 10.1016/S0140-6736(86)91431-5 ID - Gallus1986 ER - TY - STD TI - January CT, Wann LS, Alpert JS, Calkins H, Cleveland JC Jr, Cigarroa JE, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014. doi:10.1016/j.jacc.2014.03.021. [Epub ahead of print]. ID - ref7 ER - TY - STD TI - Association European Heart Rhythm, European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010;12(10):1360–420. doi:10.1093/europace/euq350. ID - ref8 ER - TY - JOUR AU - Mearns, E. S. AU - Hawthorne, J. AU - Song, J. S. AU - Coleman, C. I. PY - 2014 DA - 2014// TI - Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review JO - BMJ Open VL - 4 UR - https://doi.org/10.1136/bmjopen-2014-005379 DO - 10.1136/bmjopen-2014-005379 ID - Mearns2014 ER - TY - JOUR AU - Fitzmaurice, D. A. AU - Kesteven, P. AU - Gee, K. M. AU - Murray, E. T. AU - McManus, R. PY - 2003 DA - 2003// TI - A systematic review of outcome measures reported for the therapeutic effectiveness of oral anticoagulation JO - J Clin Pathol VL - 56 UR - https://doi.org/10.1136/jcp.56.1.48 DO - 10.1136/jcp.56.1.48 ID - Fitzmaurice2003 ER - TY - JOUR AU - Rosendaal, F. R. AU - Cannegieter, S. C. AU - Meer, F. J. AU - Briët, E. PY - 1993 DA - 1993// TI - A method to determine the optimal intensity of oral anticoagulant therapy JO - Thromb Haemost VL - 69 ID - Rosendaal1993 ER - TY - JOUR AU - Ageno, W. AU - Gallus, A. S. AU - Wittkowsky, A. AU - Crowther, M. AU - Hylek, E. M. AU - Palareti, G. PY - 2012 DA - 2012// TI - Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines JO - Chest VL - 141 UR - https://doi.org/10.1378/chest.11-2292 DO - 10.1378/chest.11-2292 ID - Ageno2012 ER - TY - JOUR AU - Connolly, S. J. AU - Pogue, J. AU - Eikelboom, J. AU - Flaker, G. AU - Commerford, P. AU - Franzosi, M. G. AU - Healey, J. S. AU - Yusuf, S. PY - 2008 DA - 2008// TI - Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range JO - Circulation VL - 118 UR - https://doi.org/10.1161/CIRCULATIONAHA.107.750000 DO - 10.1161/CIRCULATIONAHA.107.750000 ID - Connolly2008 ER - TY - JOUR AU - Apostolakis, S. AU - Sullivan, R. M. AU - Olshansky, B. AU - Lip, G. Y. PY - 2013 DA - 2013// TI - Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT2R2 score JO - Chest VL - 144 UR - https://doi.org/10.1378/chest.13-0054 DO - 10.1378/chest.13-0054 ID - Apostolakis2013 ER - TY - JOUR AU - Costa, G. L. AU - Lamego, R. M. AU - Colosimo, E. A. AU - Valacio, R. A. AU - Moreira, M. C. PY - 2012 DA - 2012// TI - Identifying potential predictors of high-quality oral anticoagulation assessed by time in therapeutic international normalized ratio range: a prospective, long-term, single-center, observational study JO - Clin Ther VL - 34 UR - https://doi.org/10.1016/j.clinthera.2012.06.002 DO - 10.1016/j.clinthera.2012.06.002 ID - Costa2012 ER - TY - JOUR AU - Mearns, E. S. AU - White, C. M. AU - Kohn, C. G. AU - Hawthorne, J. AU - Song, J. S. AU - Meng, J. AU - Schein, J. R. AU - Raut, M. K. AU - Coleman, C. I. PY - 2014 DA - 2014// TI - Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression JO - Thromb J VL - 12 UR - https://doi.org/10.1186/1477-9560-12-14 DO - 10.1186/1477-9560-12-14 ID - Mearns2014 ER - TY - JOUR AU - Mearns, E. S. AU - Kohn, C. G. AU - Song, J. S. AU - Hawthorne, J. AU - Meng, J. AU - White, C. M. AU - Raut, M. K. AU - Schein, J. R. AU - Coleman, C. I. PY - 2014 DA - 2014// TI - Meta-analysis to assess the quality of international normalized ratio control and associated outcomes in venous thromboembolism patients JO - Thromb Res VL - 134 UR - https://doi.org/10.1016/j.thromres.2014.05.035 DO - 10.1016/j.thromres.2014.05.035 ID - Mearns2014 ER - TY - JOUR AU - Erkens, P. M. AU - Cate, H. AU - Büller, H. R. AU - Prins, M. H. PY - 2012 DA - 2012// TI - Benchmark for time in therapeutic range in venous thromboembolism: a systematic review and meta-analysis JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0042269 DO - 10.1371/journal.pone.0042269 ID - Erkens2012 ER - TY - JOUR AU - Wan, Y. AU - Heneghan, C. AU - Perera, R. AU - Roberts, N. AU - Hollowell, J. AU - Glasziou, P. AU - Bankhead, C. AU - Xu, Y. PY - 2008 DA - 2008// TI - Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review JO - Circ Cardiovasc Qual Outcomes VL - 1 UR - https://doi.org/10.1161/CIRCOUTCOMES.108.796185 DO - 10.1161/CIRCOUTCOMES.108.796185 ID - Wan2008 ER - TY - JOUR AU - Cios, D. A. AU - Baker, W. L. AU - Sander, S. D. AU - Phung, O. J. AU - Coleman, C. I. PY - 2009 DA - 2009// TI - Evaluating the impact of study-level factors on warfarin control in U.S.-based primary studies: a meta-analysis JO - Am J Health Syst Pharm VL - 66 UR - https://doi.org/10.2146/ajhp080507 DO - 10.2146/ajhp080507 ID - Cios2009 ER - TY - JOUR AU - Walraven, C. AU - Jennings, A. AU - Oake, N. AU - Fergusson, D. AU - Forster, A. J. PY - 2006 DA - 2006// TI - Effect of study setting on anticoagulation control: a systematic review and metaregression JO - Chest VL - 129 UR - https://doi.org/10.1378/chest.129.5.1155 DO - 10.1378/chest.129.5.1155 ID - Walraven2006 ER - TY - JOUR AU - Reynolds, M. W. AU - Fahrbach, K. AU - Hauch, O. AU - Wygant, G. AU - Estok, R. AU - Cella, C. AU - Nalysnyk, L. PY - 2004 DA - 2004// TI - Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis JO - Chest VL - 126 UR - https://doi.org/10.1378/chest.126.6.1938 DO - 10.1378/chest.126.6.1938 ID - Reynolds2004 ER - TY - STD TI - Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM; ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883–91. ID - ref23 ER - TY - JOUR AU - Connolly, S. J. AU - Ezekowitz, M. D. AU - Yusuf, S. AU - Eikelboom, J. AU - Oldgren, J. AU - Parekh, A. AU - Pogue, J. AU - Reilly, P. A. AU - Themeles, E. AU - Varrone, J. AU - Wang, S. AU - Alings, M. AU - Xavier, D. AU - Zhu, J. AU - Diaz, R. AU - Lewis, B. S. AU - Darius, H. AU - Diener, H. C. AU - Joyner, C. D. AU - Wallentin, L. PY - 2009 DA - 2009// TI - Dabigatran versus warfarin in patients with atrial fibrillation JO - N Engl J Med VL - 361 UR - https://doi.org/10.1056/NEJMoa0905561 DO - 10.1056/NEJMoa0905561 ID - Connolly2009 ER - TY - JOUR AU - Giugliano, R. P. AU - Ruff, C. T. AU - Braunwald, E. AU - Murphy, S. A. AU - Wiviott, S. D. AU - Halperin, J. L. AU - Waldo, A. L. AU - Ezekowitz, M. D. AU - Weitz, J. I. AU - Špinar, J. AU - Ruzyllo, W. AU - Ruda, M. AU - Koretsune, Y. AU - Betcher, J. AU - Shi, M. AU - Grip, L. T. AU - Patel, S. P. AU - Patel, I. AU - Hanyok, J. J. AU - Mercuri, M. AU - Antman, E. M. PY - 2013 DA - 2013// TI - Edoxaban versus warfarin in patients with atrial fibrillation JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1310907 DO - 10.1056/NEJMoa1310907 ID - Giugliano2013 ER - TY - JOUR AU - Granger, C. B. AU - Alexander, J. H. AU - McMurray, J. J. AU - Lopes, R. D. AU - Hylek, E. M. AU - Hanna, M. AU - Al-Khalidi, H. R. AU - Ansell, J. AU - Atar, D. AU - Avezum, A. AU - Bahit, M. C. AU - Diaz, R. AU - Easton, J. D. AU - Ezekowitz, J. A. AU - Flaker, G. AU - Garcia, D. AU - Geraldes, M. AU - Gersh, B. J. AU - Golitsyn, S. AU - Goto, S. AU - Hermosillo, A. G. AU - Hohnloser, S. H. AU - Horowitz, J. AU - Mohan, P. AU - Jansky, P. AU - Lewis, B. S. AU - Lopez-Sendon, J. L. AU - Pais, P. AU - Parkhomenko, A. AU - Verheugt, F. W. AU - Zhu, J. AU - Wallentin, L. PY - 2011 DA - 2011// TI - Apixaban versus warfarin in patients with atrial fibrillation JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMoa1107039 DO - 10.1056/NEJMoa1107039 ID - Granger2011 ER - TY - JOUR AU - Schulman, S. AU - Kearon, C. AU - Kakkar, A. K. AU - Mismetti, P. AU - Schellong, S. AU - Eriksson, H. PY - 2009 DA - 2009// TI - Dabigatran versus warfarin in the treatment of acute venous thromboembolism JO - N Engl J Med VL - 361 UR - https://doi.org/10.1056/NEJMoa0906598 DO - 10.1056/NEJMoa0906598 ID - Schulman2009 ER - TY - JOUR AU - Schulman, S. AU - Kakkar, A. K. AU - Goldhaber, S. Z. AU - Schellong, S. AU - Eriksson, H. AU - Mismetti, P. AU - Christiansen, A. V. AU - Friedman, J. AU - Maulf, F. AU - Peter, N. AU - Kearon, C. PY - 2014 DA - 2014// TI - Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis JO - Circulation VL - 129 UR - https://doi.org/10.1161/CIRCULATIONAHA.113.004450 DO - 10.1161/CIRCULATIONAHA.113.004450 ID - Schulman2014 ER - TY - JOUR PY - 2010 DA - 2010// TI - Oral rivaroxaban for symptomatic venous thromboembolism JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa1007903 DO - 10.1056/NEJMoa1007903 ID - ref29 ER - TY - JOUR PY - 2012 DA - 2012// TI - Oral rivaroxaban for the treatment of symptomatic pulmonary embolism JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1113572 DO - 10.1056/NEJMoa1113572 ID - ref30 ER - TY - JOUR AU - Agnelli, G. AU - Buller, H. R. AU - Cohen, A. AU - Curto, M. AU - Gallus, A. S. AU - Johnson, M. AU - Masiukiewicz, U. AU - Pak, R. AU - Thompson, J. AU - Raskob, G. E. AU - Weitz, J. I. PY - 2013 DA - 2013// TI - Oral apixaban for the treatment of acute venous thromboembolism JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1302507 DO - 10.1056/NEJMoa1302507 ID - Agnelli2013 ER - TY - JOUR AU - Büller, H. R. AU - Décousus, H. AU - Grosso, M. A. AU - Mercuri, M. AU - Middeldorp, S. AU - Prins, M. H. AU - Raskob, G. E. AU - Schellong, S. M. AU - Schwocho, L. AU - Segers, A. AU - Shi, M. AU - Verhamme, P. AU - Wells, P. PY - 2013 DA - 2013// TI - Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1306638 DO - 10.1056/NEJMoa1306638 ID - Büller2013 ER - TY - STD TI - Razouki Z, Ozonoff A, Zhao S, et al. Improving quality measurement for anticoagulation: adding international normalized ratio variability to percent time in therapeutic range. Circ Cardiovasc Qual Outcomes 2014;7:Doi:10.1161/circoutcomes.114.00804/-/DCI. ID - ref33 ER - TY - JOUR AU - Nelson, W. W. AU - Desai, S. AU - Damaraju, C. V. PY - 2015 DA - 2015// TI - International normalized ratio stability in warfarin-experiences patients with nonvalvular atrial fibrillation JO - Am J Cardiovasc Drugs VL - 15 UR - https://doi.org/10.1007/s40256-015-0120-9 DO - 10.1007/s40256-015-0120-9 ID - Nelson2015 ER - TY - JOUR AU - Pokorney, S. AU - Simon, D. N. AU - Thomas, L. PY - 2015 DA - 2015// TI - The myth of the stable INR patient: results from ORBIT-AF JO - J Am Coll Cardiol VL - 65 UR - https://doi.org/10.1016/S0735-1097(15)60344-8 DO - 10.1016/S0735-1097(15)60344-8 ID - Pokorney2015 ER - TY - JOUR AU - Oake, N. AU - Fergusson, D. A. AU - Forster, A. J. AU - Walraven, C. PY - 2007 DA - 2007// TI - Frequency of adverse events in patients with poor anticoagulation: a meta-analysis JO - CMAJ VL - 176 UR - https://doi.org/10.1503/cmaj.061523 DO - 10.1503/cmaj.061523 ID - Oake2007 ER - TY - JOUR AU - Oake, N. AU - Jennings, A. AU - Forster, A. J. AU - Fergusson, D. AU - Doucette, S. AU - Walraven, C. PY - 2008 DA - 2008// TI - Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis JO - CMAJ VL - 179 UR - https://doi.org/10.1503/cmaj.080171 DO - 10.1503/cmaj.080171 ID - Oake2008 ER - TY - JOUR AU - Nelson, W. W. AU - Wang, L. AU - Baser, O. AU - Damaraju, C. V. AU - Schein, J. R. PY - 2014 DA - 2014// TI - Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation JO - Int J Clin Pharm ID - Nelson2014 ER - TY - JOUR AU - Nieuwlaat, R. AU - Connolly, B. J. AU - Hubers, L. M. AU - Cuddy, S. M. AU - Eikelboom, J. W. AU - Yusuf, S. AU - Connolly, S. J. PY - 2012 DA - 2012// TI - Quality of individual INR control and the risk of stroke and bleeding events in atrial fibrillation patients: a nested case control analysis of the ACTIVE W study JO - Thromb Res VL - 129 UR - https://doi.org/10.1016/j.thromres.2011.08.024 DO - 10.1016/j.thromres.2011.08.024 ID - Nieuwlaat2012 ER - TY - JOUR AU - Nelson, W. W. AU - Desai, S. AU - Damaraju, C. V. AU - Lu, L. AU - Fields, L. E. AU - Wildgoose, P. AU - Schein, J. R. PY - 2014 DA - 2014// TI - International normalized ratio stabilization in newly initiated warfarin patients with nonvalvular atrial fibrillation JO - Curr Med Res Opin VL - 30 UR - https://doi.org/10.1185/03007995.2014.957822 DO - 10.1185/03007995.2014.957822 ID - Nelson2014 ER - TY - JOUR AU - Laliberte, F. AU - Cloutier, M. AU - Nelson, W. W. PY - 2014 DA - 2014// TI - Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients JO - Curr Med Res Opin VL - 1 ID - Laliberte2014 ER - TY - JOUR AU - Nelson, W. W. AU - Song, X. AU - Thomson, E. AU - Coleman, C. I. AU - Damaraju, C. V. AU - Schein, J. R. PY - 2014 DA - 2014// TI - Medication Persistence and Discontinuation of Rivaroxaban and Warfarin Therapy among Patients with Non-valvular Atrial Fibrillation JO - Curr Med Res Opin VL - 30 UR - https://doi.org/10.1185/03007995.2014.933577 DO - 10.1185/03007995.2014.933577 ID - Nelson2014 ER - TY - JOUR AU - Lip, G. Y. AU - Nieuwlaat, R. AU - Pisters, R. AU - Lane, D. A. AU - Crijns, H. J. PY - 2010 DA - 2010// TI - Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation JO - Chest VL - 137 UR - https://doi.org/10.1378/chest.09-1584 DO - 10.1378/chest.09-1584 ID - Lip2010 ER - TY - JOUR AU - Laliberte, F. AU - Raut, M. K. AU - Nelson, W. W. PY - 2014 DA - 2014// TI - Hospital length of stay: is rivaroxaban associated with shorter inpatient stay compared to warfarin among patient with non-vavlular atrial fibrillation? JO - Curr Med Res Opin VL - 30 UR - https://doi.org/10.1185/03007995.2013.867843 DO - 10.1185/03007995.2013.867843 ID - Laliberte2014 ER - TY - JOUR AU - Laliberte, F. AU - Pilon, D. AU - Raut, M. K. PY - 2014 DA - 2014// TI - Is rivaroxaban associated with lower inpatient costs compared to warfarin among patients with non-valvular atrial fibrillation? JO - Curr Med Res Opin VL - 8 UR - https://doi.org/10.1185/03007995.2014.916159 DO - 10.1185/03007995.2014.916159 ID - Laliberte2014 ER - TY - JOUR AU - Nelson, W. W. AU - Wang, L. AU - Baser, O. AU - Damaraju, C. V. AU - Schein, J. R. PY - 2015 DA - 2015// TI - Out-of-range international normalized ratio values and health care cost among new warfarin patients with non-valvular atrial fibrillation JO - J Med Econ VL - 18 UR - https://doi.org/10.3111/13696998.2014.1001851 DO - 10.3111/13696998.2014.1001851 ID - Nelson2015 ER - TY - JOUR AU - Nelson, W. W. AU - Choi, J. C. AU - Vanderpoel, J. AU - Damaraju, C. V. AU - Wildgoose, P. AU - Fields, L. E. AU - Schein, J. R. PY - 2013 DA - 2013// TI - Impact of co-morbidities and patient characteristics on international normalized ratio control over time in patient with nonvalvular atrial fibrillation JO - Am J Cardiol VL - 112 UR - https://doi.org/10.1016/j.amjcard.2013.04.013 DO - 10.1016/j.amjcard.2013.04.013 ID - Nelson2013 ER - TY - JOUR AU - Rose, A. J. AU - Hylek, E. M. AU - Ozonoff, A. AU - Ash, A. S. AU - Reisman, J. I. AU - Berlowitz, D. R. PY - 2010 DA - 2010// TI - Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA) JO - J Thromb Haemost VL - 8 UR - https://doi.org/10.1111/j.1538-7836.2010.03996.x DO - 10.1111/j.1538-7836.2010.03996.x ID - Rose2010 ER - TY - JOUR AU - Nutescu, E. A. AU - Bathija, S. AU - Sharp, L. K. AU - Gerber, B. S. AU - Schumock, G. T. AU - Fitzgibbon, M. L. PY - 2011 DA - 2011// TI - Anticoagulation patient self-monitoring in the United States: considerations for clinical practice adoption JO - Pharmacotherapy VL - 31 UR - https://doi.org/10.1592/phco.31.12.1161 DO - 10.1592/phco.31.12.1161 ID - Nutescu2011 ER - TY - JOUR AU - Wadelius, M. AU - Chen, L. Y. AU - Eriksson, N. AU - Bumpstead, S. AU - Ghori, J. AU - Wadelius, C. AU - Bentley, D. AU - McGinnis, R. AU - Deloukas, P. PY - 2007 DA - 2007// TI - Association of warfarin dose with genes involved in its action and metabolism JO - Hum Genet VL - 121 UR - https://doi.org/10.1007/s00439-006-0260-8 DO - 10.1007/s00439-006-0260-8 ID - Wadelius2007 ER - TY - JOUR AU - Krynetskiy, E. AU - McDonnell, P. PY - 2007 DA - 2007// TI - Building individualized medicine: prevention of adverse reactions to warfarin therapy JO - J Pharmacol Exp Ther VL - 322 UR - https://doi.org/10.1124/jpet.106.117952 DO - 10.1124/jpet.106.117952 ID - Krynetskiy2007 ER - TY - JOUR AU - Rieder, M. J. AU - Reiner, A. P. AU - Gage, B. F. AU - Nickerson, D. A. AU - Eby, C. S. AU - McLeod, H. L. AU - Blough, D. K. AU - Thummel, K. E. AU - Veenstra, D. L. AU - Rettie, A. E. PY - 2005 DA - 2005// TI - Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMoa044503 DO - 10.1056/NEJMoa044503 ID - Rieder2005 ER - TY - JOUR AU - Muszkat, M. AU - Blotnik, S. AU - Elami, A. AU - Krasilnikov, I. AU - Caraco, Y. PY - 2007 DA - 2007// TI - Warfarin metabolism and anticoagulant effect: a prospective, observational study of the impact of CYP2C9 genetic polymorphism in the presence of drug-disease and drug-drug interactions JO - Clin Ther VL - 29 UR - https://doi.org/10.1016/S0149-2918(07)80081-6 DO - 10.1016/S0149-2918(07)80081-6 ID - Muszkat2007 ER - TY - JOUR AU - Aithal, G. P. AU - Day, C. P. AU - Kesteven, P. J. AU - Daly, A. K. PY - 1999 DA - 1999// TI - Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications JO - Lancet VL - 353 UR - https://doi.org/10.1016/S0140-6736(98)04474-2 DO - 10.1016/S0140-6736(98)04474-2 ID - Aithal1999 ER - TY - JOUR AU - Higashi, M. K. AU - Veenstra, D. L. AU - Kondo, L. M. AU - Wittkowsky, A. K. AU - Srinouanprachanh, S. L. AU - Farin, F. M. AU - Rettie, A. E. PY - 2002 DA - 2002// TI - Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy JO - JAMA VL - 287 UR - https://doi.org/10.1001/jama.287.13.1690 DO - 10.1001/jama.287.13.1690 ID - Higashi2002 ER - TY - STD TI - Food and Drug Administration. FDA Approves Updated Warfarin (Coumadin) Prescribing Information. August 16, 2007. Available at : http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108967.htm (Last accessed on August 4, 2014). UR - http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108967.htm ID - ref56 ER - TY - JOUR AU - Eckman, M. H. AU - Rosand, J. AU - Greenberg, S. M. AU - Gage, B. F. PY - 2009 DA - 2009// TI - Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation JO - Ann Intern Med VL - 150 UR - https://doi.org/10.7326/0003-4819-150-2-200901200-00005 DO - 10.7326/0003-4819-150-2-200901200-00005 ID - Eckman2009 ER - TY - JOUR AU - Orensky, I. A. AU - Holdford, D. A. PY - 2005 DA - 2005// TI - Predictors of noncompliance with warfarin therapy in an outpatient anticoagulation clinic JO - Pharmacotherapy VL - 25 UR - https://doi.org/10.1592/phco.2005.25.12.1801 DO - 10.1592/phco.2005.25.12.1801 ID - Orensky2005 ER - TY - JOUR AU - Platt, A. B. AU - Localio, A. R. AU - Brensinger, C. M. AU - Cruess, D. G. AU - Christie, J. D. AU - Gross, R. AU - Parker, C. S. AU - Price, M. AU - Metlay, J. P. AU - Cohen, A. AU - Newcomb, C. W. AU - Strom, B. L. AU - Laskin, M. S. AU - Kimmel, S. E. PY - 2008 DA - 2008// TI - Risk factors for nonadherence to warfarin: results from the IN-RANGE study JO - Pharmacoepidemiol Drug Saf VL - 17 UR - https://doi.org/10.1002/pds.1556 DO - 10.1002/pds.1556 ID - Platt2008 ER - TY - JOUR AU - Morisky, D. E. AU - Ang, A. AU - Krousel-Wood, M. AU - Ward, H. J. PY - 2008 DA - 2008// TI - Predictive validity of a medication adherence measure in an outpatient setting JO - J Clin Hypertens (Greenwich) VL - 10 UR - https://doi.org/10.1111/j.1751-7176.2008.07572.x DO - 10.1111/j.1751-7176.2008.07572.x ID - Morisky2008 ER - TY - JOUR AU - Coleman, C. I. AU - Coleman, S. M. AU - Vanderpoel, J. AU - Nelson, W. AU - Colby, J. A. AU - Scholle, J. M. AU - Kluger, J. PY - 2013 DA - 2013// TI - Patient satisfaction with warfarin- and non-warfarin-containing thromboprophylaxis regimens for atrial fibrillation JO - J Investig Med VL - 61 UR - https://doi.org/10.2310/JIM.0b013e31828df1bf DO - 10.2310/JIM.0b013e31828df1bf ID - Coleman2013 ER - TY - JOUR AU - Bamber, L. AU - Wang, M. Y. AU - Prins, M. H. AU - Ciniglio, C. AU - Bauersachs, R. AU - Lensing, A. W. AU - Cano, S. J. PY - 2013 DA - 2013// TI - Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of acute symptomatic deep-vein thrombosis JO - Thromb Haemost VL - 110 UR - https://doi.org/10.1160/TH13-03-0243 DO - 10.1160/TH13-03-0243 ID - Bamber2013 ER - TY - JOUR AU - Kimmel, S. E. AU - Chen, Z. AU - Price, M. AU - Parker, C. S. AU - Metlay, J. P. AU - Christie, J. D. AU - Brensinger, C. M. AU - Newcomb, C. W. AU - Samaha, F. F. AU - Gross, R. PY - 2007 DA - 2007// TI - The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study JO - Arch Intern Med VL - 167 UR - https://doi.org/10.1001/archinte.167.3.229 DO - 10.1001/archinte.167.3.229 ID - Kimmel2007 ER - TY - JOUR AU - Poller, L. AU - Keown, M. AU - Ibrahim, S. PY - 2008 DA - 2008// TI - An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage JO - J Thromb Haemost VL - 6 UR - https://doi.org/10.1111/j.1538-7836.2008.02959.x DO - 10.1111/j.1538-7836.2008.02959.x ID - Poller2008 ER - TY - JOUR AU - Christensen, T. D. AU - Larsen, T. B. PY - 2011 DA - 2011// TI - Precision and accuracy of point of care testing coagulometers used for self-testing and self management of oral anticoagulation therapy JO - J Thromb Haemost VL - 10 UR - https://doi.org/10.1111/j.1538-7836.2011.04568.x DO - 10.1111/j.1538-7836.2011.04568.x ID - Christensen2011 ER - TY - JOUR AU - Grunau, B. E. AU - Wiens, M. O. AU - Harder, K. K. PY - 2011 DA - 2011// TI - Patient self-management of warfarin therapy: pragmatic feasibility study in Canadian primary care JO - Can Fam Physician VL - 57 ID - Grunau2011 ER -